Also, a 2014 study conducted in Koreans asserted that NAFLD was the first disorder to be considered in Koreans showing elevated ALT [39], while other recent studies have reported associations between NAFLD and decreased bone mass [41–43]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.